growth/size/body
• greatly reduced after myocardial infarction relative to controls
|
• weight gain on a high fat diet is more moderate than in controls
|
cardiovascular system
• angiogenic response after carotid ligation is more moderate than in controls
|
• greatly reduced after myocardial infarction relative to controls
|
• left ventricular cavity dilation is substantially reduced after myocardial infarction
|
• left ventricular ejection fraction is better preserved than in infarcted controls
|
• improved survival rate (72% vs 48% for controls)
• reduced apoptosis at the left ventricular border zone
• myocardial hypertrophy largely prevented
|
• elevated blood pressure between 6-12 weeks of age
• blood pressure slowly decreases with age
|
• endothelium dependent relaxation by acetyl choline in aortic rings is attenuated at 12 weeks
|
• more moderate neointimal formation after carotid ligation relative to controls
|
immune system
• inflammatory response after carotid ligation is more moderate than in controls
|
• lung granuloma formation after 12 weeks if not treated with antibiotics
• lung granuloma formation after 20 weeks when treated with antibiotics
|
homeostasis/metabolism
• improved survival rate (72% vs 48% for controls)
• reduced apoptosis at the left ventricular border zone
• myocardial hypertrophy largely prevented
|
• more moderate neointimal formation after carotid ligation relative to controls
|
• at 12 weeks
|
• elevated ACE activity in tissues at 12 weeks of age
|
nervous system
• long lasting phase of LTP is slightly enhanced
|
• completely abrogated in hippocampal slices
|
behavior/neurological
• impaired contextual fear response
• cued memory is normal
|
• small but significant deficits in early training trials in water maze tests
• spatial learning impairments
|
• slightly increased time spent in the center in an open field test
|
muscle
• left ventricular ejection fraction is better preserved than in infarcted controls
|
• endothelium dependent relaxation by acetyl choline in aortic rings is attenuated at 12 weeks
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
chronic granulomatous disease | DOID:3265 |
OMIM:PS306400 |
J:111142 |